Awakn Life Sciences Corp.
Awakn Life Sciences Corp.
CSE Index:
Currency:
Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting approximately 51 million people in the US and key European markets and 285 million people globally for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercializing our R&D pipeline across multiple channels.
Awakn Life Sciences Corp. (AWKN)
SEDAR Information
Company Info
Address
301,217 Queen St W.
Toronto, ON M5V 0R2
CanadaPhone
(416) 270-9566Email
Jonathanh@awaknlifesciences.comWebsite
https://www.awaknlifesciences.comListing date
Tuesday, February 13, 2024Transfer Agent
Endeavor Trust CorporationInvestor Relations
Anthony TennysonEmail
Anthony.tennyson@awaknlifesciences.comAuditor
MNP LLPCapitalization
Issued & Outstanding:
39234054Reserved for Issuance:
18449293Company Officers
Anthony Tennyson, CEO
Jonathan Held, CFO / CBO
Prof. David Nutt, Chief Research Officer
News Releases
Bulletins
09/02/2024
2024-0213 - New Listing - Awakn Life Sciences Corp. (AWKN)
le 9 février/February 2024
The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
